Register
Login:
Share:
Email Facebook Twitter

Market analyst Rajan Dhall talks about the financial market Watch here

Market analyst Rajan Dhall talks about the financial market


Scancell Holdings Share Price (SCLP)



Share Price Information for Scancell Holdings (SCLP)


Share Price: 10.125Bid: 10.00Ask: 10.25Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 0.25Spread as %: 2.50%Open: 10.125High: 10.125Low: 10.125Yesterday’s Close: 10.125

Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
10.125

Share Price SpacerBid
10.00

Share Price SpacerAsk
10.25

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
94,780

Share Price SpacerOpen
10.125

Share Price SpacerHigh
10.125

Share Price SpacerLow
10.125

Share Price SpacerClose
10.125

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 312.06m £31.60m 10,000

52 Week High 19.75 52 Week High Date 20-JUL-2016
52 Week Low 9.88 52 Week Low Date 9-JUN-2017

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 94,769 11 -8.882 -1.14 0.00 0.00


London South East Users info for Scancell Holdings




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

23-Jun-17
15:31:27
10.00
25,000
Sell* 
10.00
10.25
2,500
Trade Type:
Ordinary

23-Jun-17
13:12:51
10.123
49,269
Sell* 
10.00
10.25
4,988
Trade Type:
Ordinary

23-Jun-17
09:13:12
10.14
11
Buy* 
10.00
10.25
1.12
Trade Type:
Ordinary




View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
11-May-17Placing
Trade Notifier Information for Scancell Holdings
John Chiplin held the position of Non-Executive Director at Scancell Holdings at the time of this trade.
 John Chiplin
10GBX1,041,1771100000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
View more Scancell Holdings directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Today 06:05CHELSEA7Morning All10.125Strong Buy
As we prepare to enter, next week Q3, thought I would brush up on the interview RG had by telephone with Proactive Investors..............................

http://www.proactiveinvestors.co.uk/companies/stocktube/7443/scancell-raises-5mln-in-most-successful-round-they-ve-ever-had-ceo-richard-goodfellow-7443.html

Talk about the Moditope Patent and the amount of commercial interest in Moditope as a result begins around around 2.15secs, followed by confirmation of sending back IND application… Read More
Sat 18:36CHELSEA7Bibio10.125No Opinion
Good to see some relevant Twitter chat here. Thanks.
Sat 17:25CHELSEA7RE: Daily Mail10.125No Opinion
Translated by the ever polite farmer...........................

Something along the lines of 'Serves you right'.
Can also mean 'I told you so' or 'No sympathy from me!'!!!!!

Charming................
Sat 16:55FarmertallyRE: Daily Mail10.125No Opinion
"The absolutely correct 'lese majeste' laws apply." :)

Som nom na?
Sat 12:51TorquayFanDaily Mail10.125Strong Buy
Thanks for that link. I cannot read it because DM has been censored here, 100% for 3 years or more. Due to DM comment and printing photos. The absolutely correct 'lese majeste' laws apply.
Under the same fight for justice, a Guy posting links recently had a 70 year sentence reduced to a mere 35.

Thanks muchly for your insight to it though. ATB

And a nice weekend from the 'Land of Smiles'.
Sat 11:54boomorbustRE: Daily mail article10.125No Opinion
Yep - article below on BMS' Opdivo in head and neck cancer. So not a new treatment and not a vaccine but one of the PD-1 checkpoint inhibitors.

As we know, Scancell have shown in preclinical research that the combination of ImmunoBody and anti PD-1 increased response rates and resulted in 85% long term survival for SCIB1/PD-1 and 100% for SCIB2/PD1 and it is PD-1 that will be combined with SCIB1 in the forthcoming trial. Of course the potential market for combinations gets bigger with… Read More

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Scancell Holdings (SCLP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.